SARS-CoV-2 尖端突变对呈现的影响是 HLA 全形特异性的
You Min Ahn1,2, Janesha C Maddumage1,2, Emma J Grant1,2,3
1Infection & Immunity Program, La Trobe Institute for Molecular Science (LIMS), La Trobe University, Bundoora, Victoria, Australia.
Current research in structural biology
|May 14, 2024
概括
SARS-CoV-2 尖端蛋白突变影响CD8+ T细胞的反应. 我们的研究表明,这些突变以HLA全形特异的方式影响的呈现,其中一些T细胞与变异发生交叉反应.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- CD8+ T细胞对于清除SARS-CoV-2等病毒感染至关重要.
- 了解T细胞对SARS-CoV-2抗原的反应至关重要,特别是考虑到Spike蛋白中的突变.
- 尖端蛋白突变可能会影响疫苗的有效性和免疫逃避.
研究的目的:
- 描述对SARS-CoV-2的免疫反应,聚焦于阿尔法和Omicron变异的突变.
- 为了研究突变对特定HLA全形体的稳定性,构造和呈现的影响.
- 评估T细胞对变异的交叉反应性.
主要方法:
- 免疫性Spike (S976-984) 和其变体 (S982A,L981F) 与HLA-A*02:01.01结合的特性.
- 一个较长的重叠的识别 (S975-984),呈现出多个HLA异形 (HLA-A*02:01,HLA-A*11:01,HLA-B*13:01).
- 对 CD8+ T 细胞对突变的交叉反应性的评估.
主要成果:
- 阿尔法变异突变 (S982A) 改变了与HLA-A*02:01.01结合的的稳定性和形状.
- 一个更长的 (S975-984) 被确定,由几个HLA全态呈现.
- 特定于S975的CD8+T细胞对突变的交叉反应性很弱,即使在HLA-A*11:01.1上具有类似的构造,也表现得很弱.
- SARS-CoV-2 突变对呈现的影响取决于特定的 HLA 全形.
结论:
- SARS-CoV-2 突变对不同 HLA 全形体的呈现有不同的影响.
- 接种疫苗后的T细胞表现出对变体的反应性和交叉反应性,这表明对SARS-CoV-2变体的免疫反应的潜力.
相关概念视频
Antigens Involved in Adaptive Immunity
486
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
486
Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Single Nucleotide Polymorphisms-SNPs
15.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.0K
Antigen Processing Pathways
1.0K
MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
MHC Class I: Presenting Endogenous...
1.0K
Mutations
82.0K
Overview
82.0K


